GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (NYSE:CRL) » Definitions » Cyclically Adjusted PB Ratio

Charles River Laboratories International (Charles River Laboratories International) Cyclically Adjusted PB Ratio : 5.66 (As of May. 21, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Charles River Laboratories International Cyclically Adjusted PB Ratio?

As of today (2024-05-21), Charles River Laboratories International's current share price is $221.48. Charles River Laboratories International's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $39.11. Charles River Laboratories International's Cyclically Adjusted PB Ratio for today is 5.66.

The historical rank and industry rank for Charles River Laboratories International's Cyclically Adjusted PB Ratio or its related term are showing as below:

CRL' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.99   Med: 6   Max: 19.58
Current: 5.7

During the past years, Charles River Laboratories International's highest Cyclically Adjusted PB Ratio was 19.58. The lowest was 1.99. And the median was 6.00.

CRL's Cyclically Adjusted PB Ratio is ranked worse than
84.96% of 133 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.98 vs CRL: 5.70

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Charles River Laboratories International's adjusted book value per share data for the three months ended in Mar. 2024 was $70.673. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $39.11 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Charles River Laboratories International Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Charles River Laboratories International's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charles River Laboratories International Cyclically Adjusted PB Ratio Chart

Charles River Laboratories International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.01 11.94 14.59 6.95 6.36

Charles River Laboratories International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.12 6.10 5.45 6.36 6.93

Competitive Comparison of Charles River Laboratories International's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Charles River Laboratories International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Cyclically Adjusted PB Ratio falls into.



Charles River Laboratories International Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Charles River Laboratories International's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=221.48/39.11
=5.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Charles River Laboratories International's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=70.673/131.7762*131.7762
=70.673

Current CPI (Mar. 2024) = 131.7762.

Charles River Laboratories International Quarterly Data

Book Value per Share CPI Adj_Book
201406 14.325 100.560 18.772
201409 14.333 100.428 18.807
201412 14.203 99.070 18.892
201503 14.016 99.621 18.540
201506 14.978 100.684 19.603
201509 15.108 100.392 19.831
201512 15.698 99.792 20.729
201603 16.552 100.470 21.709
201606 17.583 101.688 22.786
201609 18.341 101.861 23.728
201612 17.667 101.863 22.855
201703 18.399 102.862 23.571
201706 20.247 103.349 25.816
201709 21.586 104.136 27.316
201712 22.047 104.011 27.932
201803 23.793 105.290 29.778
201806 24.624 106.317 30.521
201809 26.055 106.507 32.237
201812 27.325 105.998 33.970
201903 28.681 107.251 35.240
201906 29.818 108.070 36.359
201909 31.376 108.329 38.167
201912 33.402 108.420 40.598
202003 33.383 108.902 40.395
202006 35.294 108.767 42.760
202009 38.140 109.815 45.767
202012 42.490 109.897 50.949
202103 43.491 111.754 51.283
202106 46.009 114.631 52.890
202109 48.089 115.734 54.755
202112 50.214 117.630 56.253
202203 51.382 121.301 55.819
202206 52.058 125.017 54.873
202209 51.631 125.227 54.331
202212 58.423 125.222 61.481
202303 60.736 127.348 62.848
202306 63.428 128.729 64.930
202309 64.449 129.860 65.400
202312 70.063 129.419 71.339
202403 70.673 131.776 70.673

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Charles River Laboratories International  (NYSE:CRL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Charles River Laboratories International Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Charles River Laboratories International (Charles River Laboratories International) Business Description

Traded in Other Exchanges
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Executives
Victoria L Creamer officer: EVP & Chief People Officer 164 PINE HILL ROAD, NEW FAIRFIELD CT 06812
Joseph W Laplume officer: EVP, Corp Strategy & Develop 251 BALLARDVALE STREET, WILMINGTON MA 01887
Birgit Girshick officer: Corporate Executive VP 251 BALLARDVALE STREET, WILMINGTON MA 01887
James C Foster director, officer: President and CEO 251 BALLARDVALE ST, WILMINGTON MA 01887
Richard F Wallman director HONEYWELL, 101 COLUMBIA ROAD, MORRISTOWN NJ 07962
William D Barbo officer: Corporate Executive VP & CCO 251 BALLARDVALE STREET, WILMINGTON MA 01887
Michael Gunnar Knell officer: CSVP&Chief Accounting Officer BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
George Massaro director
Shannon M Parisotto officer: CEVP, Disc & Safety Assessment 251 BALLARDVALE ST, WILMINGTON MA 01887
Flavia Pease officer: Corporate Executive VP 251 BALLARDVALE STREET, WILMINGTON MA 01887
David Ross Smith officer: Corporate Executive VP & CFO 251 BALLARDVALE STREET, WILMINGTON MA 01887
Deborah Turner Kochevar director 251 BALLARDVALE STREET, WILMINGTON MA 01887
Milne George M Jr director
Stephen D Chubb director C/O MATRITECH INC, 330 NEVADA STREET, NEWTON MA 02460
George Llado director 251 BALLARDVALE STREET, WILMINGTON MA 01887